NAUT (Nautilus Biotechnology) Total Equity: $144.42 Mil (As of Mar. 2026)


NAUT Nautilus Biotechnology Inc NAUT
28 GF Score
Price $2.06
! 2 Warning Signs
View Full Analysis

What is Nautilus Biotechnology Total Equity?

Nautilus Biotechnology NAUT -11.89% 28 Total Equity is $144.42 Mil as of Mar. 2026. GuruFocus rates NAUT with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

Nautilus Biotechnology's total equity for the quarter that ended in Mar. 2026 was $144.42 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Nautilus Biotechnology Total Equity Historical Data

* Premium members only.

The historical data trend for Nautilus Biotechnology's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nautilus Biotechnology Total Equity Chart

Nautilus Biotechnology Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 363.58 314.92 265.35 208.73 156.97

Nautilus Biotechnology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 194.44 181.09 169.14 156.97 144.42
NAUT
28GF Score
Nautilus Biotechnology Inc NAUT
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nautilus Biotechnology Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Nautilus Biotechnology's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=191.112-34.139
=156.97

Nautilus Biotechnology's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=177.779-33.364
=144.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $144.42 Mil mean?
Nautilus Biotechnology (NAUT) has a Total Equity of $144.42 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Nautilus Biotechnology and its competitors.
Is Nautilus Biotechnology's Total Equity too high?
Nautilus Biotechnology's current Total Equity is $144.42 Mil. Overall, Nautilus Biotechnology has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Nautilus Biotechnology's Total Equity compare to IFRX and NMRA?
Nautilus Biotechnology's Total Equity of $144.42 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Nautilus Biotechnology and its competitors. Nautilus Biotechnology's current Total Equity is $144.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nautilus Biotechnology stock overvalued right now?
Nautilus Biotechnology (NAUT) has a current Total Equity of $144.42 Mil. The current Total Equity is $144.42 Mil. Nautilus Biotechnology's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Nautilus Biotechnology (NAUT), the current Total Equity is $144.42 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nautilus Biotechnology Business Description

Address 2701 Eastlake Avenue East, Seattle, WA, USA, 98102
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
28GF Score

Get the complete analysis for NAUT

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.06
Price